AxoGen | 10-Q: Quarterly report
AxoGen | 8-K: Axogen, Inc Reports First Quarter 2024 Financial Results
AxoGen | EFFECT: Others
AxoGen | DEF 14A: Definitive information statements
AxoGen | ARS: Annual Report to Security Holders
AxoGen | PRE 14A: Preliminary proxy statements relating to merger or acquisition
AxoGen | S-3/A: Registration statement for specified transactions by certain issuers (Amendment)
AxoGen | 4: Statement of changes in beneficial ownership of securities-Officer Zaderej Karen L.
AxoGen | 4: Statement of changes in beneficial ownership of securities-Officer DeVinney Erick Wayne
AxoGen | 4: Statement of changes in beneficial ownership of securities-Officer Scopelianos Angelo
AxoGen | 4: Statement of changes in beneficial ownership of securities-Officer Donovan Michael Patrick
AxoGen | EFFECT: Others
AxoGen | 4: Statement of changes in beneficial ownership of securities-Officer Donovan Michael Patrick
AxoGen | 4: Statement of changes in beneficial ownership of securities-Director Freitag Gregory Gene
AxoGen | 8-K: Current report
AxoGen | 144: Notice of proposed sale of securities pursuant to Rule 144
AxoGen | 144: Notice of proposed sale of securities pursuant to Rule 144
AxoGen | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
AxoGen | S-3: Registration statement for specified transactions by certain issuers
AxoGen | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
No Data